Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
13.50
-0.55 (-3.91%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $486 million as of April 10, 2026. Its market cap has increased by 37.79% in one year.
Market Cap
486.00M
Enterprise Value
241.23M
1-Year Change
37.79%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $486.00M, an increase of 93.62%. That is a compound annual growth rate of 16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 486.00M | 31.83% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 543.47M |
| Zura Bio | 538.92M |
| Lyell Immunopharma | 537.60M |
| Upstream Bio | 532.23M |
| Larimar Therapeutics | 529.80M |
| Fulcrum Therapeutics | 522.15M |
| Shattuck Labs | 517.41M |
| Eikon Therapeutics | 507.55M |